Skip to main content
. 2021 Jan 8;9(1):33. doi: 10.3390/vaccines9010033

Figure 6.

Figure 6

The PapMV-N vaccine platform is a strong inducer of interferon (IFN) secretion. Balb/C mice, five per group, were immunized i.v. with 200 µg of PapMV, PapMV-N, or PapMV-C. Blood was harvested at either 6 h or 8 h after injection, and ELISA directed to serum IFN was performed. * p < 0.05, ** p < 0.01, and *** p < 0.001.